Pharmedium Recalls Subpotent Ephedrine Sulfate Syringes Nationwide
Pharmedium Services is recalling 5,002 pre-filled ephedrine sulfate syringes nationwide because the drug was subpotent. The voluntary recall was initiated in October 2017.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II, which indicates a reasonable probability of temporary or medically reversible adverse health consequences. The hazard is a subpotent drug, which is a risk-of-harm product where injury has not yet been reported.
Plain-English summary
Pharmedium Services, LLC has voluntarily recalled 5,002 pre-filled syringes of ePHEDrine Sulfate In 0.9% Sodium Chloride. The product is packaged in 5-count and 25-count cartons and is available by prescription only. The recall covers specific lots with expiration dates ranging from January 10, 2018, to January 21, 2018.
The reason for the recall is that the drug was found to be subpotent, meaning it did not contain the full labeled amount of the active ingredient. The recall was initiated on October 30, 2017, and was classified as Class II by the FDA. The affected products were distributed nationwide within the United States.
Consumers and healthcare providers should stop using the affected syringes and contact Pharmedium Services or their healthcare provider for further instructions. The recall status is currently terminated.
The recalled product
- Product
- ePHEDrine Sulfate In 0.9% Sodium Chloride, 5 mg per mL (50 mg per 10 mL), 10 mL Total Volume pre-filled syringes, packaged in a) 5-count cartons, NDC 71030-0003-10 and NDC 71030-0003-20, and b) 25-count cartons, NDC 71030-0003-21 and NDC 71030-0003-12, Rx Only, PharMEDium Servic
- Manufacturer
- Pharmedium Services, LLC
- Category
- Drug — Injectable
- Hazard
- Affected units
- 5,002
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- Lot #: 172950036M
- Exp. 1/21/2018
- 172940003M
- Exp. 1/20/2018
- 172880044M
- Exp. 1/14/2018
- 172840176M
- Exp. 1/11/2018
- 172920115M
- Exp. 1/18/2018
- 172840015D
- Exp. 1/10/2018
- 172930139M
- Exp. 1/19/2018.
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Pharmedium Services, LLC
See all →- SeverePharMEDium Recalls ePHEDrine Sulfate Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls nICARdipine HCl Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Rocuronium Bromide Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Rocuronium Bromide Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Fentanyl Citrate Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
Same hazard · subpotent drug
See all →- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- ModerateAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02